Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr 13;10(4):215.
doi: 10.3390/diagnostics10040215.

Liquid Biopsy as Novel Tool in Precision Medicine: Origins, Properties, Identification and Clinical Perspective of Cancer's Biomarkers

Diego Fernández-Lázaro  1 , Juan Luis García Hernández  2   3 , Alberto Caballero García  4 , Alfredo Córdova Martínez  5 , Juan Mielgo-Ayuso  5 , Juan Jesús Cruz-Hernández  3   6
Affiliations
Review

Liquid Biopsy as Novel Tool in Precision Medicine: Origins, Properties, Identification and Clinical Perspective of Cancer's Biomarkers

Diego Fernández-Lázaro et al. Diagnostics (Basel). .

Abstract

In recent years, there has been an increase in knowledge of cancer, accompanied by a technological development that gives rise to medical oncology. An instrument that allows the implementation of individualized therapeutic strategies is the liquid biopsy. Currently, it is the most innovative methodology in medical oncology. Its high potential as a tool for screening and early detection, the possibility of assessing the patient's condition after diagnosis and relapse, as well as the effectiveness of real-time treatments in different types of cancer. Liquid biopsy is capable of overcoming the limitations of tissue biopsies. The elements that compose the liquid biopsy are circulating tumor cells, circulating tumor nucleic acids, free of cells or contained in exosomes, microvesicle and platelets. Liquid biopsy studies are performed on various biofluids extracted in a non-invasive way, and they can be performed both from the blood and in urine, saliva or cerebrospinal fluid. The development of genotyping techniques, using the elements that make up liquid biopsy, make it possible to detect mutations, intertumoral and intratumoral heterogeneity, and provide molecular information on cancer for application in medical oncology in an individualized way in different types of tumors. Therefore, liquid biopsy has the potential to change the way medical oncology could predict the course of the disease.

Keywords: biofluids; cancer; circulating tumor cells; circulating tumor nucleic acids; exosomes; liquid biopsy; microvesicles; precision oncology.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Components of liquid biopsy.
Figure 2
Figure 2
Comparison of tissue biopsy and liquid biopsy.
See this image and copyright information in PMC

References

    1. Venesio T., Siravegna G., Bardelli A., Sapino A. Liquid biopsies for monitoring temporal genomic heterogeneity in breast and colon cancers. Pathobiology. 2018;85:146–154. doi: 10.1159/000473882. - DOI - PubMed
    1. Hanahan D., Weinberg R.A. Hallmarks of cancer: The next generation. Cell. 2011;144:646–674. doi: 10.1016/j.cell.2011.02.013. - DOI - PubMed
    1. Jameson J.L., Longo D.L. Precision medicine—Personalized, problematic, and promising. N. Engl. J. Med. 2015;372:2229–2234. doi: 10.1056/NEJMsb1503104. - DOI - PubMed
    1. Imamura T., Komatsu S., Ichikawa D., Kawaguchi T., Miyamae M., Okajima W., Ohashi T., Arita T., Konishi H., Shiozaki A., et al. Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids. World J. Gastroenterol. 2016;22:5627. doi: 10.3748/wjg.v22.i25.5627. - DOI - PMC - PubMed
    1. Bardelli A., Pantel K. Liquid biopsies, what we do not know (yet) Cancer Cell. 2017;31:172–179. doi: 10.1016/j.ccell.2017.01.002. - DOI - PubMed